KNSA Smart Money
Kiniksa Pharmaceuticals International, plc
1W: -8.2%
1M: -2.8%
3M: -8.1%
YTD: +73.7%
1Y: +88.2%
3Y: +361.3%
5Y: +582.7%
$89.20
+16.22 (+22.23%)
After Hours: $89.50 (+0.30, +0.34%)
Weekly Expected Move ±4.7%
$70
$73
$77
$80
$84
Credit Risk of going bust: lower than 91% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down more than 99.9%), Kiniksa Pharmaceuticals International, plc would be worth roughly what it owes.
Total debt $8.9M against a stock market value of $5.69B.
Distance to default 14.80 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $4.4M (short-term plus half of long-term), stock volatility 47.9%; Altman Z'' 5.80. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $8.9M against a stock market value of $5.69B.
Distance to default 14.80 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $4.4M (short-term plus half of long-term), stock volatility 47.9%; Altman Z'' 5.80. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Megna Michael R | officer: chief accounting officer | S-Sale | 4,600 | $80.30 | $369K | Filing |
| 2026-09-01 | Moat Ross | officer: chief operating officer | F-Tax Withholding | 4,007 | $79.28 | $318K | Filing |
| 2026-09-01 | Paolini John F. | officer: chief medical officer | F-Tax Withholding | 4,029 | $79.28 | $319K | Filing |
| 2026-09-01 | Patel Sanj K | officer: chairman & ceo | F-Tax Withholding | 15,144 | $79.28 | $1.2M | Filing |
| 2026-09-01 | Megna Michael R | officer: chief accounting officer | F-Tax Withholding | 5,531 | $79.28 | $438K | Filing |
| 2026-09-01 | Ragosa Mark | officer: chief financial officer | F-Tax Withholding | 4,404 | $79.28 | $349K | Filing |
| 2026-09-01 | Patel Sanj K | officer: chairman & ceo | F-Tax Withholding | 15,144 | $79.28 | $1.2M | Filing |
| 2026-08-19 | Quart Barry D | director | G-Gift | 2,600 | $— | $0 | Filing |
| 2026-07-29 | Cole G Bradley | director | S-Sale | 3,673 | $81.43 | $299K | Filing |
| 2026-07-29 | Cole G Bradley | director | G-Gift | 4,500 | $— | $0 | Filing |
| 2026-07-15 | Megna Michael R | officer: chief accounting officer | A-Grant/Award | 279 | $33.50 | $9K | Filing |
| 2026-05-29 | BAKER BROS. ADVISORS LP | director | A-Grant/Award | 6,078 | $— | $0 | Filing |
| 2026-05-29 | 667, L.P. | director | A-Grant/Award | 6,078 | $— | $0 | Filing |
| 2026-05-29 | Baker Bros. Advisors (GP) LLC | director | A-Grant/Award | 6,078 | $— | $0 | Filing |
| 2026-05-29 | Baker Brothers Life Sciences LP | director | A-Grant/Award | 6,078 | $— | $0 | Filing |
| 2026-05-29 | BAKER FELIX | director | A-Grant/Award | 6,078 | $— | $0 | Filing |
| 2026-05-29 | BAKER JULIAN | director | A-Grant/Award | 6,078 | $— | $0 | Filing |
| 2026-05-01 | Paolini John F. | officer: chief medical officer | S-Sale | 21,097 | $54.04 | $1.1M | Filing |
| 2026-05-01 | Paolini John F. | officer: chief medical officer | S-Sale | 37,327 | $53.52 | $2.0M | Filing |
| 2026-04-30 | Patel Sanj K | officer: chairman & ceo | S-Sale | 2,141 | $54.01 | $116K | Filing |
| 2026-04-29 | Patel Sanj K | officer: chairman & ceo | S-Sale | 22,544 | $54.01 | $1.2M | Filing |
| 2026-04-28 | Patel Sanj K | officer: chairman & ceo | S-Sale | 243,596 | $52.02 | $12.7M | Filing |
| 2026-04-28 | Patel Sanj K | officer: chairman & ceo | S-Sale | 51,750 | $54.02 | $2.8M | Filing |
| 2026-04-28 | Patel Sanj K | officer: chairman & ceo | S-Sale | 113,673 | $51.47 | $5.9M | Filing |
| 2026-04-28 | Patel Sanj K | officer: chairman & ceo | S-Sale | 74,635 | $50.43 | $3.8M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
0 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| No institutional holdings found | |||||